Literature DB >> 28940456

A Closer Look at Dark Toxicity of the Photosensitizer TMPyP in Bacteria.

Daniel B Eckl1, Linda Dengler1, Marina Nemmert1, Anja Eichner2, Wolfgang Bäumler2, Harald Huber1.   

Abstract

Photodynamic inactivation of bacteria (PIB) is based on photosensitizers which absorb light and generate reactive oxygen species (ROS), killing cells via oxidation. PIB is evaluated by comparing viability with and without irradiation, where reduction of viability in the presence of the photosensitizer without irradiation is considered as dark toxicity. This effect is controversially discussed for photosensitizers like TMPyP (5,10,15,20-Tetrakis(1-methyl-4-pyridinio)porphyrin tetra(p-toluensulfonate). TMPyP shows a high absorption coefficient for blue light and a high yield of ROS production, especially singlet oxygen. Escherichia coli and Bacillus atrophaeus were incubated with TMPyP and irradiated with different light sources at low radiant exposures (μW per cm²), reflecting laboratory conditions of dark toxicity evaluation. Inactivation of E. coli occurs for blue light, while no effect was detectable for wavelengths >450 nm. Being more susceptible toward PIB, growth of B. atrophaeus is even reduced for light with emission >450 nm. Decreasing the light intensities to nW per cm² for B. atrophaeus, application of TMPyP still caused bacterial killing. Toxic effects of TMPyP disappeared after addition of histidine, quenching residual ROS. Our experiments demonstrate that the evaluation of dark toxicity of a powerful photosensitizer like TMPyP requires low light intensities and if necessary additional application of substances quenching any residual ROS.
© 2017 The American Society of Photobiology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28940456     DOI: 10.1111/php.12846

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  7 in total

1.  The Meta-Substituted Isomer of TMPyP Enables More Effective Photodynamic Bacterial Inactivation than Para-TMPyP In Vitro.

Authors:  Sebastian Schulz; Svitlana Ziganshyna; Norman Lippmann; Sarah Glass; Volker Eulenburg; Natalia Habermann; Ulrich T Schwarz; Alexander Voigt; Claudia Heilmann; Tobias Rüffer; Robert Werdehausen
Journal:  Microorganisms       Date:  2022-04-21

2.  Photoactive Pore Matrix for In Situ Delivery of a Photosensitizer in Vascular Smooth Muscle Cells Selective PDT.

Authors:  Magdalena Wawrzyńska; Maciej Duda; Iwona Hołowacz; Aleksandra Kaczorowska; Agnieszka Ulatowska-Jarża; Igor Buzalewicz; Wojciech Kałas; Edyta Wysokińska; Dariusz Biały; Halina Podbielska; Marta Kopaczyńska
Journal:  Materials (Basel)       Date:  2019-12-09       Impact factor: 3.623

3.  An Insight into Advanced Approaches for Photosensitizer Optimization in Endodontics-A Critical Review.

Authors:  Patrícia Diogo; M Amparo F Faustino; M Graça P M S Neves; Paulo J Palma; Isabel P Baptista; Teresa Gonçalves; João Miguel Santos
Journal:  J Funct Biomater       Date:  2019-09-30

4.  Copackaging photosensitizer and PD-L1 siRNA in a nucleic acid nanogel for synergistic cancer photoimmunotherapy.

Authors:  Yuanyuan Guo; Qiushuang Zhang; Qiwen Zhu; Jing Gao; Xinyuan Zhu; Haijun Yu; Yuehua Li; Chuan Zhang
Journal:  Sci Adv       Date:  2022-04-20       Impact factor: 14.957

5.  Photoinactivation of Pseudomonas aeruginosa Biofilm by Dicationic Diaryl-Porphyrin.

Authors:  Viviana Teresa Orlandi; Eleonora Martegani; Fabrizio Bolognese; Nicola Trivellin; Francesco Garzotto; Enrico Caruso
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

6.  Light-Mediated Toxicity of Porphyrin-Like Pigments from a Marine Polychaeta.

Authors:  Mariaelena D'Ambrosio; Ana Catarina Santos; Alfonso Alejo-Armijo; A Jorge Parola; Pedro M Costa
Journal:  Mar Drugs       Date:  2020-06-06       Impact factor: 5.118

Review 7.  Antimicrobial Photodynamic Therapy: Latest Developments with a Focus on Combinatory Strategies.

Authors:  Raphaëlle Youf; Max Müller; Ali Balasini; Franck Thétiot; Mareike Müller; Alizé Hascoët; Ulrich Jonas; Holger Schönherr; Gilles Lemercier; Tristan Montier; Tony Le Gall
Journal:  Pharmaceutics       Date:  2021-11-24       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.